Drug intelligence / Profile preview

artemisia asiatica extract

Development stage
Unknown
Lead developer
Addpharma
Administration
Oral
01

Overview

AD-2341 is a pharmaceutical candidate developed by **Addpharma** (a subsidiary of **Yuhan Corporation**) for the treatment of **gastritis**. It is a specific formulation of **artemisia asiatica extract**, a botanical drug derived from the *Artemisia asiatica* plant. The extract contains active flavonoids such as eupatilin and jaceosidin, which provide gastroprotective effects by stimulating the synthesis of endogenous **prostaglandins**, increasing gastric mucus secretion, and scavenging free radicals. AD-2341 has been primarily studied as a component of **AD-234**, a fixed-dose combination (FDC) therapy that pairs artemisia asiatica extract with the cytoprotective agent **rebamipide**. This combination aims to provide synergistic protection of the gastric mucosa and improve symptoms in patients with acute or chronic gastritis.

Brand names
Stillen 2XStillen2XStillen-2X
Other names
DA-9601DA9601DA 9601
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)NF-κB

Beyond the preview

Go deeper on artemisia asiatica extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on artemisia asiatica extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call